Jump to content

From journals and scientific sources

Primary sources for information and statistics.

330 topics in this forum

  1. Official guides to tapering off psychiatric medications

    By Altostrata,
    • 0 replies
    • 3,671 views

  2. Before you start a topic in Journals....

    By Altostrata,
    • 0 replies
    • 2,156 views

  3. Liver Enzymes Cytochrome P450 Drug Interaction Tables

    By Altostrata,
    • 6 replies
    • 7,706 views

  4. Papers about prolonged antidepressant withdrawal syndrome

    By Altostrata,
    • 30 replies
    • 11,181 views

  5. Important topics in Journals and Scientific Sources

    By Altostrata,
    • 3 replies
    • 3,159 views

  6. Primary sources for data, records, papers

    By Altostrata,
    • 11 replies
    • 3,118 views

  7. Lerner, 2019 Dependence, withdrawal and rebound of CNS drugs: an update and regulatory considerations for new drugs development.

    By Altostrata,
    • 2 replies
    • 315 views

  8. Massabki, 2020, Selective serotonin reuptake inhibitor ' discontinuation syndrome' or withdrawal

    By Andie,
    • 3 replies
    • 366 views

  9. Deprescribing in Psychiatry - Psychopharmacology Institute

    By DoctorMussyWasHere,
    • 0 replies
    • 125 views

  10. Kanherkar, 2018 The Effect of Citalopram on Genome-Wide DNA Methylation of Human Cells

    By Rhiannon,
    • 7 replies
    • 565 views

  11. Khan, 2018, Serotonin Syndrome Presenting with Concominant Tramadol and Diphenhydramine Use: A Case Report of an Unlikely Side Effect

    By Andie,   
    • 0 replies
    • 115 views

  12. Guidance for Psychological Therapists: Enabling conversations with clients taking or withdrawing from prescribed psychiatric drugs

    By India,
    • 0 replies
    • 203 views

  13. Read, 2019, How common and severe are six withdrawal effects from, and addiction to, antidepressants? The experiences of a large international sample of patients

    By bubbles,
    • 4 replies
    • 763 views

  14. Henssler, 2019, Antidepressant Withdrawal and Rebound Phenomena

    By bubbles,
    • 1 reply
    • 403 views

  15. Shapiro, 2018, Subtherapeutic doses of SSRI antidepressants demonstrate considerable serotonin transporter occupancy: implications for tapering SSRIs

    By bubbles,
    • 0 replies
    • 241 views

  16. Eveleigh, 2019, Patients' attitudes to discontinuing not-indicated long-term antidepressant use: barriers and facilitators

    By bubbles,
    • 0 replies
    • 199 views

  17. Fluyau, 2018 Challenges of the pharmacological management of benzodiazepine withdrawal, dependence, and discontinuation

    By Altostrata,
    • 0 replies
    • 244 views

  18. Stockmann, 2019 What it was like to stop an antidepressant

    By bubbles,
    • 5 replies
    • 545 views

  19. Hengartner, 2019,Antidepressant withdrawal – the tide is finally turning

    By Linus,
    • 1 reply
    • 406 views

  20. Munkholm Munkholm, 2019, Considering the methodological limitations in the evidence base of antidepressants for depression: a reanalysis of a network meta-analysis

    By Linus,
    • 7 replies
    • 398 views

  21. Ruhe, 2019 Comment on Horowitz, 2019 Tapering of SSRI treatment to mitigate withdrawal symptoms

    By Onmyway,   
    • 7 replies
    • 330 views

  22. Fava, 2017 The Potential Role of Iatrogenic Comorbidity in the Interaction between Pharmacotherapy and Psychotherapy in Anxiety Disorders

    By Shep,
    • 0 replies
    • 182 views

  23. Fava, 2019 Iatrogenic Factors in Psychopathology

    By Shep,
    • 0 replies
    • 223 views

  24. Baldessarini, 2019 Effects of Treatment Discontinuation in Clinical Psychopharmacology.

    By Itzakadoozee,
    • 5 replies
    • 515 views

  25. Khan, 2019 Serotonin Sensitivity and Withdrawal With Low-Dose Venlafaxine

    By Altostrata,
    • 0 replies
    • 544 views

  26. Moncrieff, 2005 Rethinking models of psychotropic drug action.

    By Altostrata,
    • 0 replies
    • 277 views

  27. Récalt, 2019 Withdrawal Confounding in Randomized Controlled Trials of Antipsychotic, Antidepressant, and Stimulant Drugs, 2000-2017.

    By Altostrata,
    • 0 replies
    • 278 views

  28. Horowitz, 2019 Tapering of SSRI treatment to mitigate withdrawal symptoms

    By Henosis,
    • 28 replies
    • 2,950 views

  29. Veltri, 2015 Medication-induced hypokalemia

    By Altostrata,
    • 0 replies
    • 173 views

  30. Aydemir, 2018 SSRI Induced Apathy Syndrome

    By Altostrata,
    • 6 replies
    • 788 views

  31. Oehrberg, 1995 Paroxetine in the treatment of panic disorder. A randomised, double-blind, placebo-controlled study.

    By Altostrata,
    • 0 replies
    • 213 views

  32. Maund, 2019 Managing Antidepressant Discontinuation: A Systematic Review.

    By Altostrata,
    • 0 replies
    • 323 views

  33. Reisman, 2017 Sexual Consequences of Post-SSRI Syndrome.

    By Altostrata,   
    • 0 replies
    • 189 views

  34. Bala, 2018 Post-SSRI Sexual Dysfunction: A Literature Review.

    By Altostrata,   
    • 0 replies
    • 212 views

  35. Papp, 2018 Brain Zaps: An Underappreciated Symptom of Antidepressant Discontinuation.

    By Altostrata,
    • 3 replies
    • 376 views

  36. Khan, 2014 Abrupt discontinuation compared with a 1-week taper regimen in depressed outpatients treated for 24 weeks with desvenlafaxine 50 mg/d.

    By Altostrata,
    • 0 replies
    • 186 views
×
×
  • Create New...

Important Information

Terms of Use Privacy Policy

  I accept